• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Central Logic Integrates Offering and Rebrands to ABOUT

Share:

October 7, 2021

What You Should Know:

– Healthcare technology company Central Logic, today announced it has rebranded as ABOUT (ABOUT Healthcare, Inc.), as the company also announces the integration of two earlier acquisitions with its core solution, to better serve health system clients across the country.

– The integration of Ensocare—which automates the inpatient referral process to post-acute care; and Acuity Link—which provides transportation communications and logistics management software—into the Central Logic portfolio creates an end-to-end solution for orchestrating patient access across the healthcare continuum.

– The ability to operate as one system of care is exemplified by the role ABOUT played in the creation and execution of the Arizona Surge Line, which ensures all COVID-19 patients across the state receive appropriate access to care. More than 100 hospitals with varying ownerships, affiliations, and EHRs participate in the Surge Line. The ABOUT solution enables the Surge Line to provide referring hospitals anywhere in Arizona with one phone number to navigate patients to the appropriate level of care, including transport coordination and real-time patient tracking.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The Surge Line does not supplant the transfer and access centers operated by participating health systems. It sits on top of and is the front door to, all of the individual transfer centers for COVID-19 referrals.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Notable Labs Lands $40M to Expand AI-based Cancer Treatment TechNotable Labs Lands $40M to Expand AI-based Cancer Treatment Tech
  • CELLTREAT Acquires Vistalab TechnologiesCELLTREAT Acquires Vistalab Technologies
  • NeuroSense Therapeutics Extends ALS Biomarker Collaboration with Massachusetts General HospitalNeuroSense Therapeutics Extends ALS Biomarker Collaboration with Massachusetts General Hospital
  • UK Remains the European Leader in Health Tech ResearchUK Remains the European Leader in Health Tech Research
  • Roivant Dives Deeper into AI with $450 Million Buy of Silicon TherapeuticsRoivant Dives Deeper into AI with $450 Million Buy of Silicon Therapeutics
  • Head of Fitbit Health Solutions Talks Payer Strategy, Evolution of Health ProductsHead of Fitbit Health Solutions Talks Payer Strategy, Evolution of Health Products
  • OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & ProstheticsOrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
  • TITLE Boxing Club Sells Out Manhattan with Franchise Agreement; Looks to Expand Throughout East CoastTITLE Boxing Club Sells Out Manhattan with Franchise Agreement; Looks to Expand Throughout East Coast

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications